CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST
- PMID: 24648995
- PMCID: PMC3916974
- DOI: 10.3892/br.2013.99
CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST
Abstract
Schistosomiasis is considered one of the most important neglected tropical diseases and remains a major public health problem in endemic countries. Toll-like receptor (TLR) ligands have been investigated as potential vaccine adjuvants for tumor and virus immunotherapy. However, few TLR ligands affecting schistosoma vaccines have been characterized. In this study, we evaluated a TLR9 ligand (CpG oligodeoxynucleotide 1826, CpG) as an adjuvant for a partially protective DNA vaccine encoding a 26-kDa glutathione S-transferase of Schistosoma japonicum (pVAX1-Sj26GST). Vaccination with pVAX1-Sj26GST in combination with CpG inhibited Treg immunosuppressive function, upregulated the production of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-4, IL-10, IL-2 and IL-6, and decreased CD4+CD8+Foxp3+ expression in vitro, which may contribute to the escape from Treg-mediated suppression during vaccination, allowing expansion of antigen-specific T cells against pathogens. In conclusion, our data demonstrated that selective TLR ligand combination may increase protective efficacy against schistosomiasis, which may synergistically antagonize Treg-mediated suppression.
Keywords: CpG oligodeoxynucleotide ligand; pVAX1-Sj26GST; vaccine.
Figures



Similar articles
-
Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.PLoS Negl Trop Dis. 2013 Apr 4;7(4):e2164. doi: 10.1371/journal.pntd.0002164. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23593527 Free PMC article.
-
Immunization with the glutathione S-transferase Sj26GST with Chi-CpG NP against Schistosoma japonicum in mice.Microb Pathog. 2024 Oct;195:106847. doi: 10.1016/j.micpath.2024.106847. Epub 2024 Aug 8. Microb Pathog. 2024. PMID: 39127365
-
Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection.PLoS One. 2012;7(7):e40359. doi: 10.1371/journal.pone.0040359. Epub 2012 Jul 3. PLoS One. 2012. PMID: 22802961 Free PMC article.
-
Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum.Exp Parasitol. 2011 Aug;128(4):427-32. doi: 10.1016/j.exppara.2011.05.012. Epub 2011 May 23. Exp Parasitol. 2011. PMID: 21624364
-
Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicum.Vaccine. 2010 Jul 19;28(32):5161-6. doi: 10.1016/j.vaccine.2010.06.012. Epub 2010 Jun 16. Vaccine. 2010. PMID: 20561603
Cited by
-
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.Vaccines (Basel). 2023 Feb 7;11(2):376. doi: 10.3390/vaccines11020376. Vaccines (Basel). 2023. PMID: 36851255 Free PMC article.
-
Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.Vaccines (Basel). 2014 Sep 2;2(3):654-85. doi: 10.3390/vaccines2030654. Vaccines (Basel). 2014. PMID: 26344751 Free PMC article. Review.
-
Pattern recognition receptor signaling and innate immune responses to schistosome infection.Front Cell Infect Microbiol. 2022 Oct 21;12:1040270. doi: 10.3389/fcimb.2022.1040270. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36339337 Free PMC article. Review.
-
Molecular mechanisms for enhanced DNA vaccine immunogenicity.Expert Rev Vaccines. 2016;15(3):313-29. doi: 10.1586/14760584.2016.1124762. Epub 2015 Dec 28. Expert Rev Vaccines. 2016. PMID: 26707950 Free PMC article. Review.
References
-
- King CH. Toward the elimination of schistosomiasis. N Engl J Med. 2009;360:106–109. - PubMed
-
- Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008;21:659–667. - PubMed
-
- Abdul-Ghani R, Loutfy N, el-Sahn A, Hassan A. Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol Res. 2009;104:955–965. - PubMed
-
- Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008. Parasitology. 2009;136:1719–1730. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials